Cite
HARVARD Citation
Waked, I. et al. (2018). Change in the hepatic profile of hepatitis C virus genotype 4–infected patients with compensated cirrhosis receiving ombitasvir, paritaprevir, and ritonavir plus ribavirin: A subanalysis of the AGATE‐II study. Journal of medical virology. 90 (11), pp. 1739-1744. [Online].